NCT01030796已完成1 期
Quitting Caffeine for Better Glucose Metabolism
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2009年12月最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 25
- 试验地点
- 2
- 主要终点
- Caffeine abstinence
研究概览
简要总结
This project is a pilot study of caffeine abstinence in coffee-drinkers who have type 2 diabetes. Evidence suggests that caffeine may impair the control of glucose levels, especially in those people who have type 2 diabetes. Eliminating caffeinated beverages from the diet might improve glucose control, but the difficulty of quitting is unknown. This pilot study will follow a small number of type 2 diabetic patients for three months after a brief intervention designed to help people quit caffeine. Data on success with maintaining abstinence and on changes in glucose control will be collected.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •6-month history of type 2 diabetes
- •impaired chronic glucose control (HbA1c >= 7%)
- •daily consumption of 250 mg caffeine or more in coffee, tea, and other caffeinated beverages
排除标准
- •use of exogenous insulin
- •use of non-diabetes medications that impact glucose metabolism
- •medical of psychiatric history that prevents participation or increases risk
- •current pregnancy
- •current participation in other clinical trials
- •deemed unable to comply with the study protocol for other reasons
结局指标
主要结局
Caffeine abstinence
时间窗: baseline, 2 weeks, 1, 2, and 3 months
次要结局
- HbA1c(Baseline, 3 months)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
Safety and Tolerability Study of MBX-2044 in Patients With Type 2 DiabetesType 2 Diabetes MellitusNCT00422487CymaBay Therapeutics, Inc.60
已完成
1 期
A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Insulin Icodec in Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2NCT04582435Novo Nordisk A/S46
已完成
不适用
Hyperglucagonaemia in Patients With Type 2 Diabetes - Role of Glucagon ClearanceDiabetesNCT02475421University Hospital, Gentofte, Copenhagen32
终止
1 期
Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed GlioblastomaGlioblastoma (GBM)NCT02046187St. Joseph's Hospital and Medical Center, Phoenix14
已完成
2 期
Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 DiabetesDiabetes Type 2NCT00934414Mannkind Corporation24